Back to
Man Group plc
STOK7 quarters
Position history for
Man Group plc's holdings in STOKE THERAPEUTICS INC
No. Man Group exited its STOK (Stoke Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 15,361 shares worth $80,799. Man Group first reported STOK in Q3 2022 and held it in 5 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$808,000
Total Shares Change
-62,939
Quarter-by-Quarter History
Other major holders of STOK: FMR LLC, RTW INVESTMENTS, LP, BlackRock, Inc.